Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches
暂无分享,去创建一个
Alessandra Bertoldo | Matteo Tonietto | Gaia Rizzo | Mattia Veronese | Paolo Zanotti-Fregonara | Sami S Zoghbi | Masahiro Fujita | M. Veronese | A. Bertoldo | P. Zanotti-Fregonara | S. Zoghbi | M. Fujita | G. Rizzo | Matteo Tonietto
[1] M Schwaiger,et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] Tuula Tolvanen,et al. Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs. , 2012, Nuclear medicine and biology.
[3] Roger N Gunn,et al. Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding , 2013, The Journal of Nuclear Medicine.
[4] Marie-Claude Asselin,et al. Quantification of PET Studies with the Very High-Affinity Dopamine D2/D3 Receptor Ligand [11C]FLB 457: Re-Evaluation of the Validity of using a Cerebellar Reference Region , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] R. Frackowiak,et al. Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Sadahiko Nishizawa,et al. Simple analytic method of 11C-flumazenil metabolite in blood. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] John D. Beaver,et al. Mathematical modelling of [11C]-(+)-PHNO human competition studies , 2013, NeuroImage.
[8] W. L. Chiou,et al. The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling Site , 1989, Clinical pharmacokinetics.
[9] S. Sanabria-Bohórquez,et al. [11C]Flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification , 2000, European Journal of Nuclear Medicine.
[10] Roger N. Gunn,et al. Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.
[11] Jeih-San Liow,et al. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Marie Davidian,et al. Nonlinear models for repeated measurement data: An overview and update , 2003 .
[13] Vesa Oikonen. Effect of tracer metabolism during sample preparation , 2014 .
[14] Claudio Cobelli,et al. Tracer Kinetics In Biomedical Research , 2000 .
[15] Alessandra Bertoldo,et al. A non-linear mixed effect modelling approach for metabolite correction of the arterial input function in PET studies , 2013, NeuroImage.
[16] Alessandra Bertoldo,et al. Improved Models for Plasma Radiometabolite Correction and their Impact on Kinetic Quantification in PET Studies , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] Cyrill Burger,et al. Tracer kinetic modelling of receptor data with mathematical metabolite correction , 1996, European Journal of Nuclear Medicine.
[18] D. Mankoff,et al. Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] Ryuji Nakao,et al. Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Fumitoshi Kodaka,et al. Quantification of Dopamine Transporter in Human Brain Using PET with 18F-FE-PE2I , 2012, The Journal of Nuclear Medicine.
[21] Mark Lubberink,et al. Comparison of Plasma Input and Reference Tissue Models for Analysing [11C]flumazenil Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] W C Eckelman,et al. Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] Chie Seki,et al. Effect of tracer metabolism on PET measurement of [11C]pyrilamine binding to histamine H1 receptors , 1999, Annals of nuclear medicine.
[24] Christopher C Rowe,et al. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. , 2005, Nuclear medicine and biology.
[25] Annelaure Damont,et al. Metabolism and Quantification of [18F]DPA-714, a New TSPO Positron Emission Tomography Radioligand , 2013, Drug Metabolism and Disposition.
[26] Effects of Metabolite Correction for Arterial Input Function on Quantitative Receptor Images With 11C-Flumazenil in Clinical Positron Emission Tomography Studies , 2004, Journal of computer assisted tomography.
[27] J C Mazziotta,et al. Estimation of Local Cerebral Protein Synthesis Rates with L-[1-11C]Leucine and PET: Methods, Model, and Results in Animals and Humans , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] Alan C. Evans,et al. Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] Mark Lubberink,et al. Evaluation of Tracer Kinetic Models for Quantification of P-Glycoprotein Function using (R)-[11C]Verapamil and PET , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] M. Pomper,et al. Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans , 2009, Journal of Nuclear Medicine.
[31] Gaia Rizzo,et al. Imaging of monoamine oxidase-A in the human brain with [11C]befloxatone: quantification strategies and correlation with mRNA transcription maps , 2014, Nuclear medicine communications.
[32] Karl Zilles,et al. Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach , 2005, NeuroImage.
[33] D. Visvikis,et al. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[34] Tadashi Nariai,et al. Metabolite analysis of [11C]flumazenil in human plasma: Assessment as the standardized value for quantitative PET studies , 1998, Annals of nuclear medicine.
[35] Alessandra Bertoldo,et al. Kinetic Modeling without Accounting for the Vascular Component Impairs the Quantification of [11C]PBR28 Brain PET Data , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Victor W Pike,et al. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. , 2009, Trends in pharmacological sciences.
[37] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] A. Gjedde,et al. Pharmacokinetics of Plasma 6-[18F]Fluoro-l-3,4-Dihydroxyphenylalanine ([18F]FDOPA) in Humans , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] Ramin V. Parsey,et al. Optimal Metabolite Curve Fitting for Kinetic Modeling of 11C-WAY-100635 , 2007, Journal of Nuclear Medicine.
[40] H. Akaike. A new look at the statistical model identification , 1974 .
[41] Christer Halldin,et al. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects , 2012, EJNMMI Research.
[42] W C Eckelman,et al. Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] Masahiro Fujita,et al. In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors , 2014, NeuroImage.
[44] Kewei Chen,et al. Image-Derived Input Function for Brain PET Studies: Many Challenges and Few Opportunities , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] Tuula Tolvanen,et al. Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[46] Nelleke Tolboom,et al. Evaluation of Tracer Kinetic Models for Analysis of [18F]FDDNP Studies , 2009, Molecular Imaging and Biology.
[47] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[48] Vincent J Cunningham,et al. Validation of a Tracer Kinetic Model for the Quantification of 5-HT2A Receptors in Human Brain with [11C]MDL 100,907 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] Paul Edison,et al. Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility , 2009, NeuroImage.
[50] Karl J. Friston,et al. Bayesian model selection for group studies , 2009, NeuroImage.
[51] Yuichi Kimura,et al. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine. , 2004, Nuclear medicine and biology.
[52] Oliver Gaemperli,et al. Detection and Quantification of Large-Vessel Inflammation with 11C-(R)-PK11195 PET/CT , 2011, The Journal of Nuclear Medicine.
[53] Talakad G. Lohith,et al. Evaluation in monkey of two candidate PET radioligands, [11C]RX‐1 and [18F]RX‐2, for imaging brain 5‐HT4 receptors , 2014, Synapse.
[54] N. Simpson,et al. PET Studies of Binding Competition between Endogenous Dopamine and the D1 Radiotracer [11C]NNC 756 , 1998, NeuroImage.
[55] Otto Muzik,et al. A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[56] Badreddine Bencherif,et al. Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods. , 2003, Nuclear medicine and biology.
[57] S. Gunn,et al. Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[58] Christer Halldin,et al. Measurement of Striatal and Extrastriatal Dopamine Transporter Binding with High-Resolution PET and [11C]PE2I: Quantitative Modeling and Test—Retest Reproducibility , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[59] Alexander Hammers,et al. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test–retest data , 2007, NeuroImage.
[60] Peter Herscovitch,et al. Propofol Decreases In Vivo Binding of 11C-PBR28 to Translocator Protein (18 kDa) in the Human Brain , 2013, The Journal of Nuclear Medicine.
[61] R. V. Van Heertum,et al. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] Roger N Gunn,et al. Determination of [11C]PBR28 Binding Potential in vivo: A First Human TSPO Blocking Study , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[63] Richard E. Carson,et al. Evaluation of the agonist PET radioligand [11C]GR103545 to image kappa opioid receptor in humans: Kinetic model selection, test–retest reproducibility and receptor occupancy by the antagonist PF-04455242 , 2014, NeuroImage.
[64] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[65] Valerie Treyer,et al. Stimulation-Induced Increases of Astrocytic Oxidative Metabolism in Rats and Humans Investigated with 1-11C-Acetate , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[66] Lula Rosso,et al. Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data , 2012, EJNMMI Research.
[67] Susan P. Hume,et al. Quantification of [11C]GB67 binding to cardiac α1-adrenoceptors with positron emission tomography: validation in pigs , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[68] Eveliina Arponen,et al. 11C-ORM-13070, a novel PET ligand for brain α2C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[69] R. Carson,et al. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET study , 2013, Brain, Behavior, and Immunity.
[70] Talakad G. Lohith,et al. Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A , 2012, The Journal of Nuclear Medicine.
[71] J C Mazziotta,et al. Modelling approach for separating blood time-activity curves in positron emission tomographic studies. , 1991, Physics in medicine and biology.
[72] Klaus Wienhard,et al. Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.